HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $2.0M of Halozyme Therapeutics, Inc.
Sold$1,990,768
$39.82Price
50,000Shares
−9%Stake
What HALO did after the filing
- The stock from Tue, Nov 9 open, $39.57
- −0.1%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Dec 22 close.
Traded Mon, Nov 8. Filed Mon, Nov 8, 6:22 PM ET, after the close. Returns use the Nov 9 open and the Dec 22 close. Not investment advice.